The platform being issued a Wells Notice by the SEC is surprising given the company’s conservative approach to digital assets listings, the report said.

Robinhood (HOOD) being issued a Wells Notice by the Securities and Exchange Commission (SEC) is surprising given the company’s very conservative approach to digital asset listings, KBW said in a research report on Monday.

KBW notes that Robinhood only offers fifteen cryptocurrencies on its U.S. platform, while some of its peers offer more than two hundred digital assets.

“We expect no change to HOOD’s current U.S. crypto operations or asset listings – and expect the SEC to bring forward a suit within the coming months,” analysts led by Kyle Voigt wrote.

“Our preliminary view is that HOOD would likely fight the SEC in court and has a higher likelihood to prevail than most U.S. competitors (if put in similar situations) given HOOD’s stricter listings standards,” the authors wrote.

Crypto trading makes up 12% of Robinhood’s revenue, the report said, and KBW assumes that the SEC will likely go after a subset of digital assets on the platform.

“The worst case scenario from a revenue-at-risk perspective is if the SEC chooses to move forward with categorizing ether (ETH) as a security – as this likely makes up ~25% of HOOD’s crypto assets/trading,” the report added.

The broker has a market perform on the stock with a $20 price target. The shares were trading 1.3% higher in early trading on Tuesday at around $18.

KBW said that Robinhood shareholders won’t have full clarity on the outcome of a potential legal case until late 2025 at the earliest, citing the regulator’s ongoing case against crypto exchange Coinbase (COIN).

The post Robinhood Would Likely Win Crypto Court Case With the SEC: KBW appeared first on Crypto Insider.

NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against AXT, Inc. (“AXT” or the “Company”) (NASDAQ: AXTI) in the United States District Court for the Eastern District of New York on behalf of all persons and entities who purchased or otherwise acquired AXT securities between March 24, 2021 and April 3, 2024, both dates inclusive (the “Class Period”). Investors have until July 5, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

Click here to participate in the action.

According to the lawsuit, defendants throughout the Class Period made materially false and/or misleading statements and/or failed to disclose that: (1) AXT, Inc. overstated its property holdings; (2) the Company did not disclose that the attempted listing of an AXT, Inc. subsidiary in China had reportedly failed; (3) AXT, Inc. routinely engaged in environmental violations and unsafe business practices; (4) AXT’s production declined in 2023; and (5) as a result, Defendants’ statements about its business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all times.

If you purchased or otherwise acquired AXT shares and suffered a loss, are a long-term stockholder, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.

Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com

The post AXT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against AXT, Inc. and Encourages Investors to Contact the Firm appeared first on Crypto Insider.

NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Innodata Inc. (NASDAQ: INOD) on behalf of long-term stockholders following a class action complaint that was filed against Innodata on February 21, 2024 with a Class Period from May 9, 2019 to February 14, 2024. Our investigation concerns whether the board of directors of Innodata have breached their fiduciary duties to the company.

The lawsuit alleges that on February 15, 2024, Wolfpack Research published a report revealing that Innodata misrepresented the nature and extent of its business and operations. The Wolfpack Report showed that Innodata’s AI is really “smoke and mirrors” and that the Company’s marketing claims are like “putting lipstick on a pig.” While the Defendants touted Innodata’s status as an AI pioneer, other companies were only hiring Innodata for cheap labor and its operations were powered by thousands of low-wage offshore workers, not proprietary AI technology. Innodata also stopped disclosing its Research and Development spend after the first quarter of 2021. The Wolfpack Report highlighted that Innodata’s total R&D investment over the past five years was only $4.4 million, with even less allocated to R&D in 2023 than what was spent on promoting its “AI” technology through press releases.
 
Throughout the Class Period, the complaint alleges Defendants made false and/or misleading statements, as well as failed to disclose material facts, including that Innodata: (1) did not have a viable AI technology; (2) its Goldengate AI platform is a rudimentary software developed by just a handful of employees; (3) it was not going to utilize AI to any significant degree for new Silicon Valley contracts; (4) it was not effectively investing in research and development for AI; and (5) based on the foregoing, Defendants lacked a reasonable basis for their positive statements about Innodata’s AI business and development and related financial results, growth, and prospects.
 
On this news, the price of Innodata common stock declined by $3.74 per share, or approximately 30.5%, on February 15, 2024.

If you are a long-term stockholder of Innodata, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Brandon Walker or Marion Passmore by email at investigations@bespc.com, by telephone at (212) 355-4648, or by filling out this contact form. There is no cost or obligation to you.

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com

The post INNODATA ALERT: Bragar Eagel & Squire, P.C. is Investigating Innodata Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm appeared first on Crypto Insider.

MELBOURNE, Australia, May 05, 2024 (GLOBE NEWSWIRE) — Since its launch six months ago, GroveX has swiftly climbed the ranks to secure the 230th position among global cryptocurrency exchanges, showcasing an impressive advancement of ten spots in the last month alone. This growth is underscored by a surge in monthly page visits, increasing by over 50%, and a steady rise in user numbers, growing by more than 10% each month. These metrics testify to GroveX’s dynamic market presence and commitment to providing superior trading experiences.

New Features to Enhance User Experience

GroveX.io is set to roll out three groundbreaking features that promise to enhance user convenience and expand the platform’s capabilities significantly:

1) Swap Functionality: The newly introduced Swap page is a game-changer for novice and experienced traders. This feature eliminates the complexity associated with traditional trading by allowing users to buy and sell cryptocurrencies directly. This is particularly advantageous for less experienced traders who can now engage with the market more efficiently without the intimidating prospect of navigating complex order books. 

2) Fiat On and Off Ramp Integration: GroveX is strategically moving to increase accessibility and has partnered with a significant financial entity to facilitate direct fiat transactions. Users can now deposit USDT directly into GroveX accounts and instantly swap it for any listed cryptocurrency. This integration supports users from most countries worldwide, though it requires users to complete a Know Your Customer (KYC) process, ensuring compliance and security.

3) Mobile and Web Application Redesign: GroveX is enhancing its platform’s functionality and aesthetics. The upcoming major redesign of the GroveX mobile apps — available on both Android https://play.google.com/store/apps/details?id=com.grovex and iOS https://apps.apple.com/au/app/grovexc/id647140114 — will align with the new look of the GroveX.io website. This redesign will integrate the latest features and provide a unified, user-friendly interface that enhances the overall user experience across devices.

Commitment to Future Innovations

The enhancements at GroveX are just the beginning. The platform is dedicated to continuous improvement and innovation. Future developments include the introduction of bot trading, enabling automated strategies that help users maximize their trading efficiency. Instant withdrawals will provide immediate access to funds, adding convenience and flexibility for all users.

Moreover, GroveX is pioneering a revolutionary insurance feature that covers losses even when mistakenly sending funds to the wrong wallet. This reflects GroveX’s commitment to security and customer support, ensuring users can trade confidently and in peace of mind.

An Invitation to Trade with GroveX

GroveX is determined to revolutionize the cryptocurrency market with its transparent design and forward-thinking vision. As the platform continues to grow and evolve, it remains focused on offering competitive advantages to its users, including some of the lowest trading fees in the industry, fixed at 0.05% for both makers and takers.

Join the future of cryptocurrency trading by choosing GroveX, where innovative solutions meet reliability and user-centric design. Trade now and leverage the full potential of your investments with GroveX’s advanced trading platform.  

For more information, visit https://grovex.io or contact on AdminGroveX@grovex.io

An infographic accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/eb44d7b3-e1fe-4ecf-b2c6-551e05afdfe9

The post GroveX Sets New Standards in Cryptocurrency Trading with Rapid Growth and Innovative Features appeared first on Crypto Insider.

French singer Joyce Jonathan debuts in the variety show Ride the Wind 2024.
[Photo: Courtesy of Mango TV]

CHANGSHA, China, May 06, 2024 (GLOBE NEWSWIRE) — This show is a music competition as well as international cultural exchange platform, featuring accomplished females from worldwide. In this show, 36 international female stars from France, the United States, Russia, China and other countries were invited. Their wonderful performances have been loved by many audiences, making “Ride the Wind 2024” outstanding among the likes.

The show explores to integrate traditional Chinese cultural elements and a variety of other cultural styles, presented by the brilliant stage performances of the 36 contestants.

Joyce Jonathan is a French pop singer and songwriter. Her music style is mainly pop and folk. She released her first album Sur Mes Gardes in 2009 and gained great success and popularity from it.

On the stage themed traditional Chinese twenty-four solar terms, Joyce Jonathan made her debut with the classic French folk song “Les Champs-Elysées”, showcasing the charm of French music to the Chinese audience.

In the latest episode of the show, Joyce Jonathan challenged a newly adapted Chinese song. Her performance was greatly enjoyed by the audiences. In addition, she tried a new music style, learning a traditional Chinese drama, Yue Opera, from the guests of “Ride the Wind 2024”.

Joyce commented, “The Chinese artists, or sisters, and crew members, in the show are really open-minded and inclusive. They make me feel that China is like home.” When talking about the reasons for her participation in this show, she said, “China and France have developed a friendship lasting as long as 60 years. I hope that my participation will bring more possibilities for French-China cultural exchanges.”

Media contact:
Liu Shiyi
shiyi@mgtv.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/477e01f5-89af-4bc7-badf-1d62761ac39d

The post Chinese variety show “Ride the Wind 2024” receives its first French singer Joyce Jonathan appeared first on Crypto Insider.

LOUISVILLE, Ky., May 04, 2024 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (“CDI”) announced today that NBC Sports will continue to host the Kentucky Derby on NBC and Peacock through 2032. CDI’s partnership with NBC Sports began in 2001. This multi-year partnership extension will make NBC the first media company to present the most prestigious event in horse racing for over three decades.

“As we celebrate the 150^th running of the Kentucky Derby, Churchill Downs is proud to extend the relationship with NBC Sports,” said Churchill Downs CEO Bill Carstanjen. “As our media partner for the last 23 years, NBC has artfully captured the most exciting two minutes in sports and the spectacle of the senses that surrounds it.”

“Telling the rich stories surrounding the Kentucky Derby on the first Saturday in May is part of the fabric of NBC Sports, and we are thrilled to continue that tradition with Churchill Downs,” said Rick Cordella, President, NBC Sports. “We look forward to surrounding the Kentucky Oaks and Kentucky Derby with wall-to-wall coverage and extensive promotion on the platforms of NBCUniversal.”

The extension includes multiplatform rights to the Kentucky Derby, Kentucky Oaks, and Derby and Oaks Day programming, which will be presented on NBC, Peacock, USA Network and additional NBCU platforms.

About Churchill Downs Incorporated

Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) has been creating extraordinary entertainment experiences for nearly 150 years, beginning with the company’s most iconic and enduring asset, the Kentucky Derby. Headquartered in Louisville, Kentucky, CDI has expanded through the development of live and historical racing entertainment venues, the growth of the TwinSpires horse racing online wagering business and the operation and development of regional casino gaming properties. www.churchilldownsincorporated.com 

This news release contains various “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by the use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “predict,” “project,” “seek,” “should,” “will,” “scheduled,” and similar words or similar expressions (or negative versions of such words or expressions), although some forward-looking statements are expressed differently.

Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. Important factors, that could cause actual results to differ materially from expectations include the following: the occurrence of extraordinary events, such as terrorist attacks, public health threats, civil unrest, and inclement weather, including as a result of climate change; the effect of economic conditions on our consumers’ confidence and discretionary spending or our access to credit, including the impact of inflation; additional or increased taxes and fees; the impact of any pandemics, epidemics, or outbreaks of infectious diseases, including possible new variants of COVID-19, and related economic matters on our results of operations, financial conditions and prospects; lack of confidence in the integrity of our core businesses or any deterioration in our reputation; loss of key or highly skilled personnel, as well as general disruptions in the general labor market; the impact of significant competition, and the expectation that competition levels will increase; changes in consumer preferences, attendance, wagering, and sponsorships; risks associated with equity investments, strategic alliances and other third-party agreements; inability to respond to rapid technological changes in a timely manner; concentration and evolution of slot machine and historical racing machine (HRM) manufacturing and other technology conditions that could impose additional costs; failure to enter into or maintain agreements with industry constituents, including horsemen and other racetracks; inability to successfully focus on market access and retail operations for our TwinSpires sports betting business and effectively compete; online security risk, including cyber-security breaches, or loss or misuse of our stored information as a result of a breach including customers’ personal information could lead to government enforcement actions or other litigation; reliance on our technology services and catastrophic events and system failures disrupting our operations; inability to identify, complete, or fully realize the benefits of our proposed acquisitions, divestitures, development of new venues or the expansion of existing facilities on time, on budget, or as planned; difficulty in integrating recent or future acquisitions into our operations; cost overruns and other uncertainties associated with the development of new venues and the expansion of existing facilities; general risks related to real estate ownership and significant expenditures, including risks related to environmental liabilities; personal injury litigation related to injuries occurring at our racetracks; compliance with the Foreign Corrupt Practices Act or other similar laws and regulations, or applicable anti-money laundering regulations; payment-related risks, such as risk associated with fraudulent credit card or debit card use; work stoppages and labor problems; risks related to pending or future legal proceedings and other actions; highly regulated operations and changes in the regulatory environment could adversely affect our business; restrictions in our debt facilities limiting our flexibility to operate our business; failure to comply with the financial ratios and other covenants in our debt facilities and other indebtedness; increases to interest rates (due to inflation or otherwise), disruption in the credit markets or changes to our credit ratings may adversely affect our business; increase in our insurance costs, or inability to obtain similar insurance coverage in the future, and any inability to recover under our insurance policies for damages sustained at our properties in the event of inclement weather and casualty events; and other factors described under the heading “Risk Factors” in our most recent Annual Report on Form 10-K and in other filings we make with the Securities and Exchange Commission.

We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

The post Churchill Downs Incorporated and NBC Sports Extend Historic Partnership appeared first on Crypto Insider.

LOUISVILLE, Ky., May 04, 2024 (GLOBE NEWSWIRE) — Churchill Downs Incorporated (Nasdaq: CHDN) (the “Company”, “CDI”) announced today that a jubilant crowd of nearly 157,000 Derby fans gathered at Churchill Downs Racetrack (“Churchill Downs”) to celebrate and witness Mystik Dan claim the Garland of Roses at the 150^th running of the Kentucky Derby presented by Woodford Reserve at 18-1 odds under mostly cloudy skies. Wagering from all sources was the highest all-time on the Kentucky Derby race, the Kentucky Derby Day program, and Kentucky Derby Week races.

Mystik Dan, owned by 4 G Racing, LLC (Brent Gasaway), Lance Gasaway, Daniel Hamby, III, and Valley View Farm, LLC (Scott Hamby), trained by Kenneth McPeek, bred in Kentucky by Lance Gasaway, Daniel Hamby, and 4 G Racing, LLC, and ridden by Brian Hernandez Jr., rallied from off the pace to win by a nose in a photo finish. Mystik Dan covered the mile and a quarter in 2:03.34 over a fast track. This marks an extraordinary weekend of racing for trainer Kenneth McPeek and jockey Brian Hernandez Jr. who scored victories in both the Kentucky Oaks and Kentucky Derby.

Wagering from all sources on the Kentucky Derby Day program set a new record of $320.5 million, beating last year’s record of $288.7 million. All-sources wagering on the Kentucky Derby race was a new record of $210.7 million, beating the previous record of $188.7 million set in 2023. All-sources handle for Derby Week rose to a new record of $446.6 million, beating last year’s record of $412.0 million.

TwinSpires, the official betting partner of the Kentucky Derby, handled a new record of $92.1 million in wagering on Churchill Downs races for the Kentucky Derby Day program, compared to last year’s record of $75.5, including all settled future wagers and affiliate wagering. TwinSpires’ handle on the Kentucky Derby race was a new record of $60.9 million, beating last year’s record of $48.9 million, including all settled future wagers and affiliate wagering.

The Kentucky Derby race continued to attract global attention with two starters from Japan with Forever Young finishing third and T O Password finishing fifth. Forever Young was the winner of the UAE Derby in Dubai and T O Password qualified through the Japan Road to the Derby. All-sources wagering from Japan on the Kentucky Derby race was a new record of $10.1 million, beating the previous record of $8.3 million in 2022.

CDI debuted the all-new Paddock with two new luxury reserved seating areas – The Woodford Reserve Paddock Club and Sports Illustrated’s Club SI. These luxury reserved seating areas offer customers an opportunity to view horses as they are saddled in the paddock and experience the thrill of the races from the rail of the racetrack.

“The Kentucky Derby is a testament to the enduring spirit of sportsmanship, unity and the power of tradition. We were honored to debut our transformational new Paddock as we celebrated this milestone 150^th Run for the Roses. The new Paddock has fundamentally enhanced the experience of all of our guests as they pass through our front gates and is a stepping stone to the next chapter of this time-honored event,” said Bill Carstanjen, CEO of CDI. “We expect the Kentucky Derby Week Adjusted EBITDA to reflect a new record with $26 to $28 million of growth over the prior record set last year. As we reflect on 150 years of our storied past, we remain committed to innovating new experiences for Derby fans.”

Use of Non-GAAP Measures

In addition to the results provided in accordance with GAAP, the Company also uses non-GAAP measures, including adjusted net income, adjusted diluted EPS, EBITDA (earnings before interest, taxes, depreciation and amortization), and Adjusted EBITDA.

The Company uses non-GAAP measures as a key performance measure of the results of operations for purposes of evaluating performance internally. These measures facilitate comparison of operating performance between periods and help investors to better understand the operating results of the Company by excluding certain items that may not be indicative of the Company’s core business or operating results. The Company believes the use of these measures enables management and investors to evaluate and compare, from period to period, the Company’s operating performance in a meaningful and consistent manner. The non-GAAP measures are a supplemental measure of our performance that is not required by, or presented in accordance with, GAAP, and should not be considered as an alternative to, or more meaningful than, net income or diluted EPS (as determined in accordance with GAAP) as a measure of our operating results.

We use Adjusted EBITDA to evaluate segment performance, develop strategy, and allocate resources. We utilize the Adjusted EBITDA metric to provide a more accurate measure of our core operating results and enable management and investors to evaluate and compare from period to period our operating performance in a meaningful and consistent manner. Adjusted EBITDA should not be considered as an alternative to operating income as an indicator of performance, as an alternative to cash flows from operating activities as a measure of liquidity, or as an alternative to any other measure provided in accordance with GAAP. Our calculation of Adjusted EBITDA may be different from the calculation used by other companies and, therefore, comparability may be limited.

Adjusted net income and adjusted diluted EPS exclude discontinued operations net income or loss; net income or loss attributable to noncontrolling interest; changes in fair value for interest rate swaps related to Rivers Des Plaines; Rivers Des Plaines’ legal reserves and transaction costs; transaction expense, which includes acquisition and disposition related charges, as well as legal, accounting, and other deal-related expense; pre-opening expense; and certain other gains, charges, recoveries, and expenses.

Adjusted EBITDA includes our portion of EBITDA from our equity investments.

Adjusted EBITDA excludes:

• Transaction expense, net which includes:
  • Acquisition, disposition, and property sale related charges;
  • Other transaction expense, including legal, accounting, and other deal-related expense;
• Stock-based compensation expense;
• Asset impairments;
• Gain on property sales;
• Legal reserves;
• Pre-opening expense; and
• Other charges, recoveries, and expenses.

About Churchill Downs Incorporated

Churchill Downs Incorporated (“CDI”) (Nasdaq: CHDN) has been creating extraordinary entertainment experiences for nearly 150 years, beginning with the company’s most iconic and enduring asset, the Kentucky Derby. Headquartered in Louisville, Kentucky, CDI has expanded through the development of live and historical racing entertainment venues, the growth of the TwinSpires horse racing online wagering business and the operation and development of regional casino gaming properties. www.churchilldownsincorporated.com 

This news release contains various “forward-looking statements” within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are typically identified by the use of terms such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “predict,” “project,” “seek,” “should,” “will,” “scheduled,” and similar words or similar expressions (or negative versions of such words or expressions), although some forward-looking statements are expressed differently.

Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. Important factors, that could cause actual results to differ materially from expectations include the following: the occurrence of extraordinary events, such as terrorist attacks, public health threats, civil unrest, and inclement weather, including as a result of climate change; the effect of economic conditions on our consumers’ confidence and discretionary spending or our access to credit, including the impact of inflation; additional or increased taxes and fees; the impact of any pandemics, epidemics, or outbreaks of infectious diseases, including possible new variants of COVID-19, and related economic matters on our results of operations, financial conditions and prospects; lack of confidence in the integrity of our core businesses or any deterioration in our reputation; loss of key or highly skilled personnel, as well as general disruptions in the general labor market; the impact of significant competition, and the expectation that competition levels will increase; changes in consumer preferences, attendance, wagering, and sponsorships; risks associated with equity investments, strategic alliances and other third-party agreements; inability to respond to rapid technological changes in a timely manner; concentration and evolution of slot machine and historical racing machine (HRM) manufacturing and other technology conditions that could impose additional costs; failure to enter into or maintain agreements with industry constituents, including horsemen and other racetracks; inability to successfully focus on market access and retail operations for our TwinSpires sports betting business and effectively compete; online security risk, including cyber-security breaches, or loss or misuse of our stored information as a result of a breach including customers’ personal information could lead to government enforcement actions or other litigation; reliance on our technology services and catastrophic events and system failures disrupting our operations; inability to identify, complete, or fully realize the benefits of our proposed acquisitions, divestitures, development of new venues or the expansion of existing facilities on time, on budget, or as planned; difficulty in integrating recent or future acquisitions into our operations; cost overruns and other uncertainties associated with the development of new venues and the expansion of existing facilities; general risks related to real estate ownership and significant expenditures, including risks related to environmental liabilities; personal injury litigation related to injuries occurring at our racetracks; compliance with the Foreign Corrupt Practices Act or other similar laws and regulations, or applicable anti-money laundering regulations; payment-related risks, such as risk associated with fraudulent credit card or debit card use; work stoppages and labor problems; risks related to pending or future legal proceedings and other actions; highly regulated operations and changes in the regulatory environment could adversely affect our business; restrictions in our debt facilities limiting our flexibility to operate our business; failure to comply with the financial ratios and other covenants in our debt facilities and other indebtedness; increases to interest rates (due to inflation or otherwise), disruption in the credit markets or changes to our credit ratings may adversely affect our business; increase in our insurance costs, or inability to obtain similar insurance coverage in the future, and any inability to recover under our insurance policies for damages sustained at our properties in the event of inclement weather and casualty events; and other factors described under the heading “Risk Factors” in our most recent Annual Report on Form 10-K and in other filings we make with the Securities and Exchange Commission.

We do not undertake any obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

The post Mystik Dan Wins the Historic 150th Running of the Kentucky Derby Presented by Woodford Reserve appeared first on Crypto Insider.

Wilmington, Delaware, May 03, 2024 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Memristor Market by Type (Molecular and Ionic Thin Film Memristors and Spin and Magnetic Memristors), and Industry Vertical (Consumer Electronics, IT and Telecommunication, Automotive, Healthcare, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2032″. According to the report, the memristor market was valued at $0.2 billion in 2023, and is estimated to reach $9.7 billion by 2032, growing at a CAGR of 51.93% from 2024 to 2032. 

Download Research Report Sample & TOC: 
https://www.alliedmarketresearch.com/request-sample/1856  

(We are providing report as per your research requirement, including the Latest Industry Insight’s Evolution, Potential and COVID-19 Impact Analysis) 

• 125 – Tables 
• 47 – Charts 
• 250 – Pages

Prime Determinants of Growth

The memristor market is expected to witness notable growth owing to increase in demand for IoT, cloud computing, and big data. Moreover, rise in adoption of edge computing solutions is expected to provide lucrative opportunities for the growth of the market during the forecast period. However, the complexity in technological application limits the growth of the memristor market.

Report Coverage & Details:

The molecular & ionic thin film memristors segment to maintain its leadership status during the forecast period  

On the basis of type, the molecular & ionic thin film memristors segment held the highest market share in 2023, accounting for nearly three-fifths of the global memristor market revenue and is estimated to maintain its leadership status during the forecast period, owing to their potential to revolutionize electronics by offering ultra-compact, low-power, and high-density memory solutions. These thin film memristors enable advancements in wearable devices, IoT applications, and neuromorphic computing, driving innovation and market growth in semiconductor technologies. However, the spin and magnetic memristors segment is projected to attain the highest CAGR of 52.52% from 2023 to 2032.  

Get Customized Reports with your Requirements:
https://www.alliedmarketresearch.com/request-for-customization/1856

The IT and Telecom segment to maintain its leadership status during the forecast period.  

On the basis of industry vertical, the consumer electronics segment held the highest market share in 2023, accounting for more than two-fifths of the global memristor market revenue and is estimated to maintain its leadership status during the forecast period, owing to the widespread adoption of memristor in tablets, watches, smartphones and other smart wearable devices globally. However, the others segment is projected to attain the highest CAGR of 57.21% from 2023 to 2032.

North America to maintain its dominance by 2032.

On the basis of region, North America held the highest market share in terms of revenue in 2023, accounting for nearly one-third of the memristor industry revenue owing to the high rate of investment in R&D by local players and the highly informed integrator base of memristor components compared to other regions. Many of the prominent market players are US-based, and the country is also one of the most prominent contributors to a majority of the applications of memristors, including neuromorphic computing, automotive, flexible electronics, IoT, edge computing, and industrial robotics in the recent past.

However, Asia-Pacific is projected to manifest the highest CAGR of 54.35% from 2023 to 2032 owing to developments and innovations in the regional neuromorphic computing, IoT, and storage memory market, especially by local players, are anticipated to augment the market growth for the memristor technology. Moreover, rise in demand for consumer electronics products in the Asia-Pacific region is expected to accelerate the growth of the global memristor market.

Leading Market Players: –  

• Crossbar Inc.  
• Panasonic Corporation  
• 4DS Memory Limited  
• Micron Technologies Inc.  
• Samsung Group  
• Sony Corporation 
• Intel Corporation
• IBM Corporation  
• SK Hynix Inc.  
• Toshiba Corp.  

The report provides a detailed analysis of these key players in the global Memristor Market. These players have adopted different strategies such as product launch, product development, partnership, investment, acquisition, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.   

Inquiry before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/1856 

Key Benefits For Stakeholders: 

• This memristor industry report provides a quantitative analysis of the memristor chip market segments, current trends, estimations, and dynamics of the memristor market analysis from 2023 to 2032 to identify the prevailing memristor market opportunities. 
• The market research is offered along with information related to key drivers, restraints, and opportunities. 
• Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network. 
• In-depth analysis of the memristor market segmentation assists to determine the prevailing memristor neuromorphic computing market opportunities. 
• Major countries in each region are mapped according to their revenue contribution to the global market. 
• Memristor manufacturer positioning facilitates benchmarking and provides a clear understanding of the present position of the market players. 
• The report includes the analysis of the regional as well as global memristor market trends, key memristor manufacturer, market segments, application areas, and market growth strategies. 

Procure Complete Report (250 Pages PDF with Insights, Charts, Tables, and Figures) @ https://www.alliedmarketresearch.com/Memristor-Market 

Memristor Market Key Segments: 

By Type 

• Molecular and Ionic thin film memristors 
• Spin and magnetic memristors 

By Industry Vertical 

• Consumer Electronics 
• IT and Telecommunication 
• Automotive 
• Healthcare 
• Others 

By Region: 

• North America (U.S., Canada, and Mexico) 
• Europe (UK, Germany, France, Russia, and Rest of Europe) 
• Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific) 
• Latin America (Brazil, Argentina, and Rest of Latin America) 
• Middle East and Africa (UAE, Saudi Arabia, and Rest of Middle East and Africa) 

Access AVENUE – A Subscription-Based Library (Premium On-Demand, Subscription-Based Pricing Model) @ https://www.alliedmarketresearch.com/library-access 

Avenue is a user-based library of global market report database, provides comprehensive reports pertaining to the world’s largest emerging markets. It further offers e-access to all the available industry reports just in a jiffy. By offering core business insights on the varied industries, economies, and end users worldwide, Avenue ensures that the registered members get an easy as well as single gateway to their all-inclusive requirements. 

Avenue Library Subscription | Request For 14 Days Free Trial of Before Buying: 
https://www.alliedmarketresearch.com/avenue/trial/starter  

Trending Reports in Semiconductor and Electronics Industry:

Carbon Resistor Market size was valued at $2.5 billion in 2022, and is projected to reach $4.1 billion by 2032, growing at a CAGR of 5.6% from 2023 to 2032 

Thin Film Chip Resistor Market was valued at $631.2 million in 2021, and is projected to reach $1.1 billion by 2031, growing at a CAGR of 5.4% from 2022 to 2031 

Chip Resistor Market size accounted for $999.4 million in 2020, and is expected to reach $1,567.2 million by 2028, registering a CAGR of 5.9% from 2021 to 2028 

Organic Electronic Market size is expected to reach from $46.12 billion in 2019 to $159.11 billion by 2027, growing at a CAGR of 21.0% from 2020 to 2027 

About Us: 

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports Insights” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain. 

We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry. 

Contact: 

David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285 
help@alliedmarketresearch.com

The post Memristor Market to Reach $9.7 billion, Globally, by 2032 at 51.93% CAGR: Allied Market Research appeared first on Crypto Insider.

NEW YORK, May 03, 2024 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Exscientia plc. (NASDAQ: EXAI), and Akero Therapeutics, Inc. (NASDAQ: AKRO). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Exscientia plc. (NASDAQ: EXAI)

Class Period: March 23, 2022 – Febraury 12, 2024

Lead Plaintiff Deadline: June 25, 2024

Exscientia in an artificial intelligence (“AI”) driven Pharma-tech company that engages in the design and develop differentiated medicines for diseases with high unmet patient needs.

At all relevant times, the Company purported to “maintain[] the highest standards of business conduct and ethics” and, to that end, adopted a Code of Business Conduct and Ethics which applies to all of its employees, officers and directors, including former Chief Executive Officer (“CEO”) and Director Defendant Andrew Hopkins (“Hopkins”), former Chairman of the Company’s Board of Directors (the “Board”) Defendant David Nicholson (“Nicholson”), and all other executive and senior officers.

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operations, and prospects. Specifically, Defendants made false and/or misleading statements and/or failed to disclose that: (i) Defendant Hopkins had engaged in improper relationships with employees that were inconsistent with the Company’s standards and values; (ii) Defendant Nicholson had prior knowledge of Defendant Hopkins’s relationships and had improperly addressed Hopkins’s misconduct without consulting the Board; (iii) the Company’s maintenance and enforcement of its Code of Business Conduct and Ethics was inadequate to safeguard against the foregoing conduct; (iv) the foregoing failures subjected the Company to a heightened risk of disruptive leadership transitions and/or reputational harm; and (v) as a result, Defendants’ public statements were materially false and/or misleading at all relevant times.

On February 13, 2024, Exscientia issued a press release “announc[ing] that its Board of Directors (the ‘Board’) has decided to terminate the employment of [Defendant] Hopkins as the Company’s [CEO] and Principal Executive Officer, and to remove Dr. Hopkins from his role as an Executive Director of the Board, in each case for cause and effective immediately.” The press release further revealed that the Board’s decision was taken following an investigation which found that Defendant Hopkins had “engaged in relationships with two employees that the Board determined were inappropriate and inconsistent with the Company’s standards and values.” In addition, the press release indicated that during the course of the investigation, the Board learned that “[Defendant] Nicholson [. . .] had prior knowledge of the existence of the earlier of Dr. Hopkins’ relationships and had addressed the situation directly, and with the involvement of other outside counsel, rather than in consultation with the Board,” and “[f]ollowing discussions with the Board, on February 12, 2024 Dr. Nicholson tendered his resignation from his positions with the Company.”

On this news, Exscientia’s stock price fell $1.72 per share, or 22.9%, to close at $5.79 per share on February 13, 2024.

For more information on the Exscientia class action go to: https://bespc.com/cases/EXAI

Akero Therapeutics, Inc. (NASDAQ: AKRO)

Class Period: September 13, 2022 – October 9, 2023 (Common Stock Only)

Lead Plaintiff Deadline: June 25, 2024

Akero is a clinical stage biopharmaceutical company focused on advancing its lead product candidate efruxifermin (“EFX”) to provide a new treatment for patients with nonalcoholic steatohepatitis (“NASH”), a serious liver disease. During the Class Period, Akero claimed to be evaluating EFX in two Phase 2 clinical trials in patients with biopsy-confirmed NASH: (i) Akero’s “HARMONY” trial that tested EFX in pre-cirrhotic NASH patients; and (ii) Akero’s “SYMMETRY” trial that purportedly tested EFX in patients with NASH-induced cirrhosis.

The Akero class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) approximately 20% of the patients enrolled in the SYMMETRY study had cryptogenic cirrhosis and did not have definitive NASH at baseline; (ii) the cryptogenic cirrhotic patients included in the SYMMETRY study did not have biopsy-proven compensated cirrhosis due to definitive NASH; (iii) the results from the cryptogenic cirrhosis patients were to be excluded from the calculation of the NASH resolution secondary endpoints; (iv) Akero had introduced a confounding factor into the SYMMETRY study’s design, materially influencing the study’s potential results and increasing the risks that the study would fail to meet its primary endpoint; (v) the SYMMETRY study did not align with U.S. Food & Drug Administration guidance for testing a drug in treating NASH cirrhotics because Akero had not ruled out potential causes of each patient’s cirrhosis other than NASH; and (vi) consequently, Akero had materially misrepresented the nature of the SYMMETRY trial, its usefulness in supporting any new drug application, the likelihood that the SYMMETRY trial would be successful as measured by its primary endpoint, and the likelihood that EFX would become a commercial treatment for NASH cirrhotics.

The filed complaint further alleges that it was not until Akero disclosed the study’s 36-week results on October 10, 2023 that the market finally began to learn the truth, with investors suffering substantial losses and damages under the federal securities laws as the price of Akero stock plummeted nearly 70% in response, according to the Akero class action lawsuit.

For more information on the Akero class action go to: https://bespc.com/cases/AKRO

About Bragar Eagel & Squire, P.C.:

Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York, California, and South Carolina. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:

Bragar Eagel & Squire, P.C.
Brandon Walker, Esq.
Marion Passmore, Esq.
(212) 355-4648
investigations@bespc.com
www.bespc.com

The post Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Exscientia, and Akero and Encourages Investors to Contact the Firm appeared first on Crypto Insider.

REDWOOD CITY, Calif., May 02, 2024 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (Nasdaq: SLNO), (“Soleno” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today the pricing of the underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $46.00 per share. The gross proceeds of the public offering are expected to be approximately $138.0 million, before deducting underwriting discounts and commissions and other estimated offering expenses. Soleno has also granted the underwriters a 30-day option to purchase up to 450,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The public offering is expected to close on or about May 7, 2024, subject to market conditions and the satisfaction of customary closing conditions.

Piper Sandler, Guggenheim Securities, Cantor Fitzgerald & Co. and Oppenheimer & Co. are acting as joint book-running managers for the public offering.  Laidlaw & Company (UK) Ltd. is acting as the lead manager for the public offering.

Soleno intends to use the net proceeds from this offering to fund its current research and development efforts primarily focused on advancing its lead candidate, DCCR tablets for the treatment of Prader-Willi Syndrome (PWS), and to provide for general corporate purposes, which may include working capital, capital expenditures, other clinical trials, other corporate expenses and acquisitions of complementary products, technologies or businesses, though the company does not have agreements or commitments for any specific acquisitions at this time.

The securities described above relating to the public offering are being offered by Soleno pursuant to a registration statement on Form S-3ASR (File No. 333-276344) previously filed with, and automatically declared effective by the Securities and Exchange Commission (the “SEC”) on January 2, 2024, and a preliminary prospectus supplement filed with the SEC on May 2, 2024. A final prospectus supplement and an accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC’s website located at http://www.sec.gov. When available, copies of the final prospectus supplement and the accompanying prospectus relating to this offering may be obtained from Piper Sandler & Co., 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, Attention: Prospectus Department, by telephone at (800) 747-3924, or by email at prospectus@psc.com; or Guggenheim Securities, LLC, Attention: Equity Syndicate Department, 330 Madison Avenue, 8th floor, New York, NY 10017 by telephone at (212) 518-9544, or by email at GSEquityProspectusDelivery@guggenheimpartners.com. Electronic copies of the final prospectus supplement and accompanying prospectus will also be available on the website of the SEC at www.sec.gov.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such jurisdiction. The offering will be made only by means of a prospectus supplement and the accompanying prospectus that forms a part of the registration statement.

About Soleno Therapeutics, Inc.

Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The Company’s lead candidate, DCCR (diazoxide choline) extended-release tablets, a once-daily oral tablet for the treatment of Prader-Willi syndrome (PWS), recently completed its Phase 3 development program to support a planned NDA submission.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical facts contained in this press release are forward-looking statements, including statements regarding the Company’s expectations on the completion and timing of the public offering and the anticipated use of proceeds therefrom. In some cases, you can identify forward-looking statements by terms such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of these terms or other similar expressions. These forward-looking statements speak only as of the date of this press release and are subject to a number of risks, uncertainties and assumptions, including the risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the public offering, as well as risks and uncertainties inherent in Soleno’s business, including those described in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, prior press releases and in other filings and reports filed with the SEC. The events and circumstances reflected in the Company’s forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, the Company does not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.

Corporate Contact:

Brian Ritchie
LifeSci Advisors, LLC
212-915-2578 

The post Soleno Therapeutics Announces Pricing of Approximately $138 Million Public Offering Of Common Stock appeared first on Crypto Insider.